EE04954B1 - Peroraalselt v?i paikselt manustatav farmatseutiline preparaat ja selle ravimvorm - Google Patents

Peroraalselt v?i paikselt manustatav farmatseutiline preparaat ja selle ravimvorm

Info

Publication number
EE04954B1
EE04954B1 EEP200200075A EEP200200075A EE04954B1 EE 04954 B1 EE04954 B1 EE 04954B1 EE P200200075 A EEP200200075 A EE P200200075A EE P200200075 A EEP200200075 A EE P200200075A EE 04954 B1 EE04954 B1 EE 04954B1
Authority
EE
Estonia
Prior art keywords
pharmaceutical
oral
topical administration
pharmaceutical preparation
preparation
Prior art date
Application number
EEP200200075A
Other languages
English (en)
Inventor
Andrysek Tomas
Stuchlik Milan
Vrana Ales
Jegorov Alexandr
Stuchlik Josef
Matha Vladimir
Original Assignee
Galena As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10859192&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE04954(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Galena As filed Critical Galena As
Priority to EEP200300371A priority Critical patent/EE04955B1/et
Publication of EE200200075A publication Critical patent/EE200200075A/et
Publication of EE04954B1 publication Critical patent/EE04954B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
EEP200200075A 1999-08-17 2000-08-17 Peroraalselt v?i paikselt manustatav farmatseutiline preparaat ja selle ravimvorm EE04954B1 (et)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EEP200300371A EE04955B1 (et) 1999-08-17 2000-08-17 Peroraalselt v?i paikselt manustatav farmatseutiline preparaat ja selle ravimvorm

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9919288A GB2355656B (en) 1999-08-17 1999-08-17 Pharmaceutical compositions for oral and topical administration
PCT/GB2000/003161 WO2001012229A1 (en) 1999-08-17 2000-08-17 Pharmaceutical compositions for oral and topical administration

Publications (2)

Publication Number Publication Date
EE200200075A EE200200075A (et) 2003-04-15
EE04954B1 true EE04954B1 (et) 2008-02-15

Family

ID=10859192

Family Applications (2)

Application Number Title Priority Date Filing Date
EEP200300371A EE04955B1 (et) 1999-08-17 2000-08-17 Peroraalselt v?i paikselt manustatav farmatseutiline preparaat ja selle ravimvorm
EEP200200075A EE04954B1 (et) 1999-08-17 2000-08-17 Peroraalselt v?i paikselt manustatav farmatseutiline preparaat ja selle ravimvorm

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EEP200300371A EE04955B1 (et) 1999-08-17 2000-08-17 Peroraalselt v?i paikselt manustatav farmatseutiline preparaat ja selle ravimvorm

Country Status (40)

Country Link
US (1) US20070190132A1 (et)
EP (2) EP1334717B1 (et)
JP (2) JP2003507343A (et)
KR (2) KR100828747B1 (et)
CN (2) CN1382061A (et)
AR (2) AR025324A1 (et)
AT (2) ATE402691T1 (et)
AU (1) AU777740B2 (et)
BR (1) BR0013385A (et)
CA (2) CA2380951C (et)
CO (1) CO5380014A1 (et)
CY (1) CY1105318T1 (et)
CZ (2) CZ296591B6 (et)
DE (2) DE60018081T2 (et)
DK (2) DK1210119T3 (et)
EE (2) EE04955B1 (et)
EG (1) EG23994A (et)
ES (2) ES2311077T3 (et)
GB (1) GB2355656B (et)
HK (1) HK1049629A1 (et)
HR (1) HRP20020154B1 (et)
HU (1) HUP0203236A3 (et)
IL (4) IL148200A0 (et)
JO (1) JO2324B1 (et)
MX (1) MXPA02001631A (et)
NO (2) NO20020760L (et)
NZ (1) NZ517271A (et)
PE (1) PE20010636A1 (et)
PL (1) PL192769B1 (et)
PT (2) PT1210119E (et)
RU (2) RU2279894C2 (et)
SA (1) SA00210487B1 (et)
SG (1) SG143019A1 (et)
SI (1) SI1210119T1 (et)
SK (2) SK286083B6 (et)
TN (1) TNSN00173A1 (et)
UA (2) UA72539C2 (et)
UY (1) UY26303A1 (et)
WO (1) WO2001012229A1 (et)
ZA (2) ZA200308221B (et)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration
FR2826261B1 (fr) * 2001-06-26 2005-03-25 Lmd Composition a usage topique comprenant un produit cytotoxique et son utilisation dans le traitement de l'alopeche
DE10154464B4 (de) * 2001-11-08 2005-10-20 Max Delbrueck Centrum Oral verabreichbare pharmazeutische Zubereitung umfassend liposomal verkapseltes Taxol
KR20030065831A (ko) * 2002-02-01 2003-08-09 주식회사 태평양 사이클로스포린을 함유한 지속 방출형 약학적 조성물
US9101540B2 (en) 2002-04-12 2015-08-11 Alkermes Pharma Ireland Limited Nanoparticulate megestrol formulations
US7101576B2 (en) 2002-04-12 2006-09-05 Elan Pharma International Limited Nanoparticulate megestrol formulations
EP1935407A1 (en) * 2002-12-03 2008-06-25 Elan Pharma International Limited Low viscosity liquid dosage forms
JP4518042B2 (ja) * 2002-12-04 2010-08-04 日油株式会社 コエンザイムｑ１０を含有する水溶性組成物の製造方法
KR101061679B1 (ko) * 2002-12-04 2011-09-02 닛신 파마 가부시키가이샤 코엔자임 ｑ10 을 함유하는 수용성 조성물
EP1585548B1 (en) * 2002-12-09 2018-06-27 Abraxis BioScience, LLC Compositions and methods of delivery of pharmacological agents
US6979672B2 (en) * 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules
WO2006043621A1 (ja) * 2004-10-20 2006-04-27 Kao Corporation 液体口腔用組成物
MX2007010394A (es) * 2005-02-24 2008-02-19 Elan Pharma Int Ltd Formulaciones nanoparticuladas de docetaxel y analogos del mismo.
WO2010060798A1 (en) * 2008-11-28 2010-06-03 Advance Holdings Limited Pharmaceutical formulation comprising diclofenac and a hydroxy fatty acid polyoxyalkylene ester
HRP20130304T1 (en) * 2009-03-12 2013-05-31 Lectio Pharmaentwicklungs- Und Verwertungs Gmbh Pharmaceutical formulation comprising ketoprofen and a polyoxyalkylene ester of a hydroxy fatty acid
KR101100933B1 (ko) * 2009-04-23 2012-01-02 한국기술교육대학교 산학협력단 솔더 볼 제거 장치
KR20170131641A (ko) 2015-03-27 2017-11-29 아치 퍼스널 케어 프로덕츠, 엘.피. 퍼스널 케어 제품용 점도 증강 조성물
CN112426403B (zh) * 2020-12-09 2021-09-17 南京天纵易康生物科技股份有限公司 一种口腔溃疡凝胶及其制备方法和应用
KR20250002095A (ko) * 2022-05-02 2025-01-07 추가이 세이야쿠 가부시키가이샤 계면활성제와 병용하기 위한 펩타이드 화합물을 포함하는 조성물
CN119770478B (zh) * 2024-12-31 2025-12-19 美济生物医药(广州)有限公司 紫杉醇口服药物组合物、制剂及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
CZ288631B6 (cs) * 1996-01-18 2001-08-15 Galena, A. S. Léčivé přípravky s obsahem cyklosporinu
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky
CZ267796A3 (cs) * 1996-09-12 1998-04-15 Galena A.S. Léčivé přípravky, zejména pro vnitřní aplikaci, ve formě samomikroemulgujících terapeutických systémů
CA2283780A1 (en) * 1997-03-12 1998-09-17 Abbott Laboratories Lipophilic binary systems for the administration of lipophilic compounds
KR100966245B1 (ko) * 1997-03-12 2010-06-28 아보트 러보러터리즈 사이클로스포린 투여용 친수성 2원 시스템
CN1208047C (zh) * 1997-07-29 2005-06-29 法玛西雅厄普约翰美国公司 亲脂性化合物的自体乳化剂
US6063762A (en) * 1997-12-05 2000-05-16 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition
US20030216303A1 (en) * 1998-03-06 2003-11-20 Michael Ambuhl Emulsion preconcentrates containing cyclosporin or a macrolide
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration

Also Published As

Publication number Publication date
ATE288766T1 (de) 2005-02-15
PE20010636A1 (es) 2001-06-02
JP2004238399A (ja) 2004-08-26
CY1105318T1 (el) 2010-03-03
US20070190132A1 (en) 2007-08-16
IL148200A (en) 2007-12-03
SA00210487B1 (ar) 2006-09-10
CZ2002575A3 (cs) 2003-05-14
NO20020760L (no) 2002-04-16
NO20034778D0 (no) 2003-10-24
CZ296170B6 (cs) 2006-01-11
KR100828748B1 (ko) 2008-05-09
AR025324A1 (es) 2002-11-20
KR20050095651A (ko) 2005-09-29
AU777740B2 (en) 2004-10-28
AR043106A2 (es) 2005-07-20
EP1334717A2 (en) 2003-08-13
CN101406453A (zh) 2009-04-15
ATE402691T1 (de) 2008-08-15
IL148200A0 (en) 2002-09-12
EG23994A (en) 2008-03-10
DE60322454D1 (de) 2008-09-11
ES2311077T3 (es) 2009-02-01
PL353445A1 (en) 2003-11-17
HRP20020154B1 (en) 2006-07-31
SK286083B6 (sk) 2008-03-05
EP1334717B1 (en) 2008-07-30
ZA200201315B (en) 2004-06-30
JO2324B1 (en) 2005-09-12
AU6461300A (en) 2001-03-13
GB9919288D0 (en) 1999-10-20
EP1210119A1 (en) 2002-06-05
SK2482002A3 (en) 2002-12-03
PT1334717E (pt) 2008-10-09
BR0013385A (pt) 2002-05-07
TNSN00173A1 (en) 2005-11-10
SI1210119T1 (en) 2005-06-30
UA75926C2 (en) 2006-06-15
DK1334717T3 (da) 2008-11-24
MXPA02001631A (es) 2003-07-14
HRP20020154A2 (en) 2003-12-31
CN1382061A (zh) 2002-11-27
RU2279894C2 (ru) 2006-07-20
KR100828747B1 (ko) 2008-05-09
NO20034778L (no) 2002-04-16
CA2380951A1 (en) 2001-02-22
HUP0203236A3 (en) 2004-06-28
PT1210119E (pt) 2005-05-31
EP1210119B1 (en) 2005-02-09
EE200300371A (et) 2003-10-15
KR20020059367A (ko) 2002-07-12
CA2452118A1 (en) 2001-02-22
CA2380951C (en) 2010-03-23
NO20020760D0 (no) 2002-02-15
CO5380014A1 (es) 2004-03-31
PL192769B1 (pl) 2006-12-29
CZ296591B6 (cs) 2006-04-12
EE200200075A (et) 2003-04-15
IL158108A0 (en) 2004-03-28
SG143019A1 (en) 2008-06-27
IL158108A (en) 2010-04-15
RU2003133451A (ru) 2005-04-20
HK1049629A1 (zh) 2003-05-23
NZ517271A (en) 2004-02-27
EP1334717A3 (en) 2004-01-02
HUP0203236A2 (hu) 2003-01-28
DK1210119T3 (da) 2005-06-20
DE60018081T2 (de) 2006-01-05
EE04955B1 (et) 2008-02-15
ES2237443T3 (es) 2005-08-01
RU2279895C2 (ru) 2006-07-20
UY26303A1 (es) 2001-03-16
ZA200308221B (en) 2004-09-29
JP2003507343A (ja) 2003-02-25
WO2001012229A1 (en) 2001-02-22
GB2355656B (en) 2004-04-07
GB2355656A (en) 2001-05-02
UA72539C2 (en) 2005-03-15
DE60018081D1 (de) 2005-03-17

Similar Documents

Publication Publication Date Title
EE04955B1 (et) Peroraalselt v?i paikselt manustatav farmatseutiline preparaat ja selle ravimvorm
NO20003218D0 (no) Oralfarmasøytisk doseringsform med forlenget frigivningsvirkning
EE04464B1 (et) Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE200100431A (et) 16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine
EE04275B1 (et) Kinoliini derivaadid, nende valmistamismeetodid, kasutamine ja farmatseutilised kompositsioonid
NO20014035D0 (no) System for oral administrasjon av medikament
FIU20000164U0 (fi) Uusi farmaseuttinen formulaatio
DE69812089D1 (de) Pharmazeutische omeprazol-formulierung
NO20014738D0 (no) Tolperisonholdig farmasöytisk preparat for oral administrering
EE200100470A (et) Püridopüranoasepiini derivaadid, nende valmistamine ja terapeutiline kasutamine
EE03510B1 (et) Tsisapriidi pikendatud vabastamisega ravimvorm suukaudseks manustamiseks, selle valmistamine ja kasutamine
EE200200551A (et) Oligosahhariide sisaldav farmatseutiline kompositsioon, oligosahhariidid, nende valmistamine ja raviotstarbeline kasutamine
EE04095B1 (et) Ketoliidide ja nende farmatseutiliselt vastuvõetavate soolade kasutamine farmatseutiliste kompositsioonide valmistamiseks
DE69914472D1 (de) Levosimendanhaltige oral anzuwendende arzneimittel mit gesteuerter wirkstoffverabreichung
EE200300436A (et) Imidasolidiini derivaadid, nende valmistamine ja kasutamine põletikuvastaste toimeainetena ning neid sisaldav ravimpreparaat
NO20003284D0 (no) Farmasøytisk preparat for oral administrering
HU0303147D0 (en) Pharmaceutical compositions for oral and topical administration
EE200200229A (et) Diarüülenüünid, kompositsioon ja farmatseutiline kompositsioon
DE69938347D1 (de) Medikamentöse verabreichung von nikotin in form von kaugummi

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner
KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20100817